Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Clinical Cardiology|March 1, 2023
Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United StatesMintu P Turakhia, Jennifer D Guo, Allison Keshishian, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 21, 2021
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USAAmol D Dhamane, Inmaculada Hernandez, Manuela Di Fusco, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 8, 2022
Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare databaseMuhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.Plos One|December 9, 2016
Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping ReviewAhmed M Abou-Setta, Maya Jeyaraman, Abdelhamid Attia, et al.Plos One|February 17, 2022
Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare databaseMuhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.Journal of Medical Economics|August 20, 2021
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF modelMatthew Sussman, Manuela Di Fusco, Charles Y Tao, et al.Current Medical Research and Opinion|October 11, 2021
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic reviewMatthew Sussman, Geoffrey D Barnes, Jennifer D Guo, et al.Plos One|February 14, 2017
Correction: Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping ReviewAhmed M Abou-Setta, Maya M Jeyaraman, Abdelhamid Attia, et al.JAMA Network Open|August 16, 2021
Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal BleedingGregory Y H Lip, Allison V Keshishian, Yan Zhang, et al.JACC. Cardiooncology|October 4, 2021
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active CancerSteven Deitelzweig, Allison V Keshishian, Yan Zhang, et al.Pageof 4